Charles Schwab Investment Management Inc Allakos Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.0 - $1.45 $151,975 - $220,363	-151,975 Reduced 83.63%	29,756 $29,000
Q2 2023 Aug 09, 2023	BUY	$3.6 - $5.25 $547,110 - $797,868	151,975 Added 510.74%	181,731 $792,000
Q4 2022 Feb 13, 2023	SELL	$5.66 - $8.42 $39,903 - $59,361	-7,050 Reduced 19.15%	29,756 $250,000
Q3 2022 Nov 14, 2022	SELL	$3.02 - $6.12 $358,431 - $726,358	-118,686 Reduced 76.33%	36,806 $226,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $217,331 - $513,236	-83,589 Reduced 34.96%	155,492 $487,000
Q1 2022 May 13, 2022	SELL	$5.08 - $9.81 $53,467 - $103,250	-10,525 Reduced 4.22%	239,081 $1.36 Million
Q4 2021 Feb 11, 2022	BUY	$8.55 - $111.89 $49,897 - $652,990	5,836 Added 2.39%	249,606 $2.44 Million
Q3 2021 Nov 16, 2021	BUY	$76.53 - $110.43 $302,446 - $436,419	3,952 Added 1.65%	243,770 $25.8 Million
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $2.02 Million - $2.7 Million	23,631 Added 10.93%	239,818 $20.5 Million
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $849,310 - $1.19 Million	7,740 Added 3.71%	216,187 $24.8 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $1.9 Million - $3.63 Million	23,825 Added 12.9%	208,447 $29.2 Million
Q3 2020 Nov 13, 2020	BUY	$66.43 - $90.99 $907,234 - $1.24 Million	13,657 Added 7.99%	184,622 $15 Million
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $893,307 - $1.64 Million	20,284 Added 13.46%	170,965 $12.3 Million
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $500,512 - $1.05 Million	11,250 Added 8.07%	150,681 $6.7 Million
Q4 2019 Feb 07, 2020	BUY	$66.49 - $137.73 $262,834 - $544,446	3,953 Added 2.92%	139,431 $13.3 Million
Q3 2019 Nov 08, 2019	BUY	$31.0 - $89.73 $2.16 Million - $6.26 Million	69,725 Added 106.04%	135,478 $10.7 Million
Q2 2019 Aug 09, 2019	BUY	$36.0 - $44.73 $353,700 - $439,472	9,825 Added 17.57%	65,753 $2.85 Million
Q1 2019 May 14, 2019	BUY	$33.79 - $51.99 $435,992 - $670,826	12,903 Added 29.99%	55,928 $2.27 Million
Q4 2018 Feb 14, 2019	BUY	$31.59 - $62.65 $43,246 - $85,767	1,369 Added 3.29%	43,025 $2.25 Million
Q3 2018 Nov 13, 2018	BUY	$31.25 - $47.64 $1.3 Million - $1.98 Million	41,656 New	41,656 $1.88 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$21 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$7.81 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$6.35 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$4.46 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.91 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $108M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account